Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight loss has captured more public attention.

Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Semaglutide is a drug used for weight loss. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you may need to take them ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...